Beacon Pharmaceuticals Ltd. reported earnings results for the full year ended June 30, 2021. For the full year, the company reported sales was BDT 7,121.15 million compared to BDT 5,590.79 million a year ago. Net income was BDT 863.17 million compared to BDT 380.69 million a year ago. Basic earnings per share from continuing operations was BDT 3.74 compared to BDT 1.65 a year ago.